Utility of fractional exhaled nitric oxide (FeNO) in assessing asthma control following inhaled corticosteroid treatment

Anant Mohan (New Delhi, India), Anant Mohan, V. Kavitha, Karan Madan, Vijay Hadda, Randeep Guleria, G.C. Khilnani

Source: International Congress 2016 – Assessing lower airway inflammation with different tools
Session: Assessing lower airway inflammation with different tools
Session type: Poster Discussion
Number: 1845
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Anant Mohan (New Delhi, India), Anant Mohan, V. Kavitha, Karan Madan, Vijay Hadda, Randeep Guleria, G.C. Khilnani. Utility of fractional exhaled nitric oxide (FeNO) in assessing asthma control following inhaled corticosteroid treatment. Eur Respir J 2016; 48: Suppl. 60, 1845

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Domiciliary diurnal variation of fractional exhaled nitric oxide (FeNO) to monitor asthma control
Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Year: 2013

The experience of monitoring the exhaled nitric oxide (FeNO) during the anti-IgE-therapy (omalizumab) in children with uncontrolled severe asthma
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015


The effect of bronchodilation and spirometry on exhaled nitric oxide
Source: International Congress 2016 – Paediatric asthma: recurrent, persistent, or severe obstruction and lung function techniques
Year: 2016


Clinical usefulness of fractional exhaled nitric oxide (FeNO) as a marker of long-term asthma control
Source: Annual Congress 2009 - Airway inflammation and asthma control
Year: 2009

Non-adherence to inhaled corticosteroid therapy as an explanation for persistently elevated exhaled nitric oxide levels in patients with asthma: Effect of directly observed therapy with inhaled corticosteroids (DOT-ICS)
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015


Fractional exhaled nitric oxide (FeNO) for an early diagnosis of asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 677s
Year: 2006

The levels of exhaled nitric oxide in controlled asthmatic patients with and without rhinitis
Source: International Congress 2016 – Airway biomarkers
Year: 2016


Changes of exhaled nitric oxide during steroid treatment of childhood asthma
Source: Eur Respir J 2002; 19: 1015-1019
Year: 2002



Dynamics of the nitric oxide metabolites in the exhaled breath condensate (EBC) in atopic asthma (BA) children receiving various treatment options
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013

Usefulness of fractional exhaled nitric oxide (FeNO) as a marker of asthma control
Source: Annual Congress 2008 - Phenotyping of asthma and COPD
Year: 2008

Assessment of exhaled breath condensate contamination during measurement of nitric oxide metabolites
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015

Relation of asthma control and exhaled nitric oxide in patients with bronchial hyperresponsiveness to methacholine
Source: Annual Congress 2013 –New issues in lung function testing
Year: 2013


Exhaled nitric oxide and asthma control: a longitudinal study in unselected patients
Source: Eur Respir J 2008; 31: 539-546
Year: 2008



Fractional exhaled nitric oxide (FeNO) suppression with directly observed inhaled corticosteroid therapy: does it make a difference to patient outcomes?
Source: International Congress 2018 – Clinical and functional monitoring in airway disease
Year: 2018

Optimising inhaled corticosteroid (ICS) dose using exhaled nitric oxide (eNO) measurements
Source: Eur Respir J 2003; 22: Suppl. 45, 34s
Year: 2003

Comparison of exhaled nitric oxide values measured by two offline methods or NO breath
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013


Exhaled nitric oxide variations during oral challenge with different NSAIDs in patients with aspirin-induced asthma
Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding
Year: 2016

Fractional exhaled nitric oxide (FeNO) could be a good predictor for the effectiveness of inhaled corticosteroid (ICS) in patients with COPD
Source: Annual Congress 2009 - Clinical aspects of inflammatory airways diseases
Year: 2009

Predicting response to corticosteroid in COPD using exhaled nitric oxide
Source: Annual Congress 2009 - Drug effects in COPD
Year: 2009


Exhaled nitric oxide predicts control in patients with difficult-to-treat asthma
Source: Eur Respir J 2010; 35: 1221-1227
Year: 2010